53m
Hosted on MSNHalozyme Therapeutics (HALO) Q4 Earnings and Revenues Top EstimatesHalozyme Therapeutics (HALO) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $0.82 per share a year ago.
The glue made by scientists from MIT could prove to be a viable alternative to the other offerings in the market for biomedical use.
Nishit Agarwal exemplifies excellence in Biomedical AI and Signal Processing with extensive experience in developing ...
Roanoke and Carilion Clinic combined to remake both the skyline and professional prospects in a city looking for a new ...
Clearside Biomedical, Inc. (NASDAQ:CLSD), currently valued at $81.15 million, is a biotechnology company focused on developing innovative therapies for blinding eye diseases using its proprietary SCS ...
Since the enactment of National Security Law in June 2020 in Hong Kong, the city’s exports to the US have been subject to the same tariffs as those imposed on Chinese goods.
Countries that were once able to benefit from both China’s foreign direct investment and US trade and aid programs now face ...
A research team led by Professor Kevin Tsia, programme director of the Biomedical Engineering Programme under the Faculty of Engineering of the University of Hong Kong (HKU), has developed an ...
The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.
Stroke patients in Berkshire may benefit from a new virtual reality treatment. A recent study has shown promising results for helping stroke patients regain arm movements using virtual reality ...
Georgia Life Sciences said that the immediate impact on university research would cause downstream harm to the biomedical industry in the state.
China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results